ANI Pharmaceuticals Stock Guidance | NASDAQ:ANIP | Benzinga

ANI Pharmaceuticals issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

											Get Alert
11/07/2025	ANIP	ANI Pharmaceuticals	FY	2025	$7.37	$7.64	$6.73	$854.00M	$873.00M	$847.08M	Get Alert
08/08/2025	ANIP	ANI Pharmaceuticals	FY	2025	$6.98	$7.35	$5.97	$818.00M	$843.00M	$790.83M	Get Alert
06/04/2025	ANIP	ANI Pharmaceuticals	FY	2025	$6.27	$6.62	$6.34	$768.00M	$793.00M	$769.62M	Get Alert
05/09/2025	ANIP	ANI Pharmaceuticals	FY	2025	$6.27	$6.62	$6.34	$768.00M	$793.00M	$769.64M	Get Alert
02/28/2025	ANIP	ANI Pharmaceuticals	FY	2025	$6.12	$6.49	$5.56	$756.00M	$776.00M	$724.88M	Get Alert
01/13/2025	ANIP	ANI Pharmaceuticals	FY	2025	—	—	—	$739.00M	$759.00M	$720.30M	Get Alert
11/08/2024	ANIP	ANI Pharmaceuticals	FY	2024	$4.90	$5.05	$4.72	$594.00M	$602.00M	$590.31M	Get Alert
08/06/2024	ANIP	ANI Pharmaceuticals	FY	2024	$4.38	$4.82	$4.49	$540.00M	$560.00M	$554.60M	Get Alert
05/14/2024	ANIP	ANI Pharmaceuticals	FY	2024	—	—	—	$520.00M	$542.00M	$513.14M	Get Alert
05/10/2024	ANIP	ANI Pharmaceuticals	FY	2024	$4.26	$4.67	$4.48	$520.00M	$542.00M	$535.11M	Get Alert
04/17/2024	ANIP	ANI Pharmaceuticals	FY	2024	$4.26	$4.67	$4.47	$520.00M	$542.00M	$534.15M	Get Alert
03/12/2024	ANIP	ANI Pharmaceuticals	FY	2024	$4.26	$4.67	$4.46	$520.00M	$542.00M	$535.28M	Get Alert
02/29/2024	ANIP	ANI Pharmaceuticals	FY	2024	$4.26	$4.67	$4.33	$520.00M	$542.00M	$501.09M	Get Alert
11/08/2023	ANIP	ANI Pharmaceuticals	FY	2023	$4.29	$4.57	$4.08	$468.00M	$478.00M	$452.94M	Get Alert
09/12/2023	ANIP	ANI Pharmaceuticals	FY	2023	$3.62	$4.11	$3.97	$425.00M	$445.00M	$442.97M	Get Alert
08/30/2023	ANIP	ANI Pharmaceuticals	FY	2023	$3.62	$4.11	$3.97	$425.00M	$445.00M	$442.97M	Get Alert
08/09/2023	ANIP	ANI Pharmaceuticals	FY	2023	$3.62	$4.11	$3.31	$425.00M	$445.00M	$406.41M	Get Alert
06/09/2023	ANIP	ANI Pharmaceuticals	FY	2023	—	—	—	$385.00M	$410.00M	$403.52M	Get Alert
05/08/2023	ANIP	ANI Pharmaceuticals	FY	2023	$2.99	$3.45	$2.43	$385.00M	$410.00M	$361.82M	Get Alert
03/09/2023	ANIP	ANI Pharmaceuticals	FY	2023	$2.09	$2.59	$2.62	$360.00M	$385.00M	$352.49M	Get Alert
11/09/2022	ANIP	ANI Pharmaceuticals	FY	2022	$1.34	$1.62	$1.37	$295.00M	$315.00M	$302.88M	Get Alert
08/08/2022	ANIP	ANI Pharmaceuticals	FY	2022	$1.34	$1.62	$1.43	$295.00M	$315.00M	$304.50M	Get Alert
05/10/2022	ANIP	ANI Pharmaceuticals	FY	2022	$1.34	$1.62	$1.15	$295.00M	$315.00M	$292.77M	Get Alert
03/15/2022	ANIP	ANI Pharmaceuticals	FY	2022	—	—	—	$260.00M	$275.00M	$301.57M	Get Alert

FAQ

What is the most recent guidance for ANI Pharmaceuticals (ANIP)?

The most recent guidance for ANI Pharmaceuticals (ANIP) was reported on November 7, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $7.37 to $7.64, compared to the estimated EPS of $6.73. Additionally, ANI Pharmaceuticals forecasted revenue between $0.85B and $0.87B for the quarter.

Browse guidance and forecast on all stocks.